8HP-26128-66127
3 vaccinations
1 coded response
6 check-ins
1 free-text entry
0 call cases
- Sex
- —
- Age at first dose
- 31-35
- ZIP prefix
- 017 / MA
- Registered
- 2021-02-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-26
Dose 1 — Moderna
-
2021-02-03
Registered in v-safe
-
2021-02-03
Survey response — day 7, dose 1MedDRA: Injection site erythema, Injection site pruritus, Injection site swelling, Rash macular — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Rash, not including the immediate area around the injection siteFree text: Red blotch, swelling, minor itching appeared below the injection site day 7 after injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
-
2021-02-23
Dose 2 — Moderna
-
2021-12-21
Dose 3 — Moderna
-
2021-12-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-12-24
- 2021-12-30
- 2022-01-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Moderna | |
| 2 | 2021-02-23 | Moderna | No |
| 3 | 2021-12-21 | Moderna | No |
Free text
Release 3 — day 7, dose 1
Systemic reaction (other): Red blotch, swelling, minor itching appeared below the injection site day 7 after injection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Rash macular | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release